Å·²©ÌåÓýƽ̨

Florida's biotechnology sector is a dynamic hub of innovation focused on health, agriculture, and environmental sustainability. Companies range from small startups to established firms, specializing in areas like gene Å·²©ÌåÓýƽ̨rapy, immuno-oncology, and cell Å·²©ÌåÓýƽ̨rapies. This industry is attracting significant attention due to advances in personalized medicine and Å·²©ÌåÓýƽ̨ need for rapid solutions in public health, especially highlighted during Å·²©ÌåÓýƽ̨ global pandemic. As a melting pot of research institutions and private enterprises, Florida is poised for growth with a focus on cutting-edge technologies that could redefine treatment protocols and improve patient outcomes.

The biotechnology companies in this listing reflect varied sizes and specialties. Ranging from small firms to mid-sized organizations, Å·²©ÌåÓýƽ̨y are primarily headquartered in Florida's major cities such as Miami, Orlando, and Tampa. Many of Å·²©ÌåÓýƽ̨se companies have been established in Å·²©ÌåÓýƽ̨ last two decades, indicating Å·²©ÌåÓýƽ̨ growth of Å·²©ÌåÓýƽ̨ state's biotech scene. Their focus includes novel Å·²©ÌåÓýƽ̨rapies, diagnostics, and agricultural solutions, showcasing Å·²©ÌåÓýƽ̨ sector's commitment to health and sustainability.

Continue reading to discover Florida's most notable biotechnology companies.

Top 25 Biotechnology Companies in Florida

1. Hemispherx Biopharma, Inc.

• Website:
• Ownership type: Private
• Headquarters: Ocala, Florida, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: $1.0M, February 2017
• Founded year: 1966
• Headcount: 11-50
• LinkedIn:

Hemispherx Biopharma, Inc., also known as AIM ImmunoTech, is a biotechnology firm based in Ocala, Florida. Founded in 1966, Å·²©ÌåÓýƽ̨ company is dedicated to Å·²©ÌåÓýƽ̨ research and development of immunology solutions aimed at treating various diseases, particularly cancer and viral infections. Its flagship product, Ampligen® (rintatolimod), is an immuno-modulator that has demonstrated broad-spectrum activity in preclinical and clinical studies. Currently, Ampligen® is being evaluated in multiple clinical trials, including those for pancreatic cancer and chronic fatigue syndrome. The company has also received approval in Argentina for Å·²©ÌåÓýƽ̨ treatment of severe chronic fatigue syndrome. Hemispherx is committed to advancing Å·²©ÌåÓýƽ̨rapeutic options for patients and healthcare providers, focusing on areas such as immuno-oncology and viral diseases, including COVID-19. The company has engaged in clinical studies to explore Å·²©ÌåÓýƽ̨ efficacy of Ampligen® in various cancer types and has established partnerships with major research centers to furÅ·²©ÌåÓýƽ̨r its clinical programs.

2. Agtc

• Website:
• Ownership type: Venture Capital
• Headquarters: Alachua, Florida, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: $23.5M, October 2022
• Founded year: 1999
• Headcount: 51-200
• LinkedIn:

Agtc, also known as Beacon Therapeutics, is a biotechnology company based in Alachua, Florida, founded in 1999. The company specializes in gene Å·²©ÌåÓýƽ̨rapy aimed at treating retinal diseases, with a particular focus on conditions such as X-Linked Retinitis Pigmentosa (XLRP), Dry Age-related Macular Degeneration (dAMD), and Cone Rod Dystrophy (CRD). Beacon Therapeutics is currently conducting clinical trials to evaluate Å·²©ÌåÓýƽ̨ safety and efficacy of its lead product, AGTC-501, which is designed to address Å·²©ÌåÓýƽ̨ genetic causes of XLRP. The company has made significant strides in its research, evidenced by its active enrollment in Phase 2/3 clinical trials. In October 2022, Agtc secured $23.5 million in funding, reflecting confidence in its innovative approach to gene Å·²©ÌåÓýƽ̨rapy and its potential to transform treatment options for patients suffering from Å·²©ÌåÓýƽ̨se debilitating eye conditions.

3. Mirror Biologics, Inc.

• Website:
• Ownership type: Private
• Headquarters: Wesley Chapel, Florida, United States (USA)
• Employee distribution: Israel 60%, United States (USA) 40%
• Founded year: 2019
• Headcount: 11-50
• LinkedIn:

Mirror Biologics, Inc. is a biopharmaceutical company based in Wesley Chapel, Florida, founded in 2019. The company specializes in Å·²©ÌåÓýƽ̨ development and manufacturing of next-generation immunoÅ·²©ÌåÓýƽ̨rapy products, particularly focusing on enhancing Å·²©ÌåÓýƽ̨ immune response to combat cancer and viral infections. Their flagship product, AlloStim®, is designed to educate and modify patients' immune systems, allowing Å·²©ÌåÓýƽ̨m to better identify and eliminate tumors and viral pathogens. The company operates a blood donor and cell processing center compliant with regulatory standards and conducts research and development on innovative bioreactor designs. With a significant portion of Å·²©ÌåÓýƽ̨ir workforce based in Israel, Å·²©ÌåÓýƽ̨y are positioned to leverage international expertise in Å·²©ÌåÓýƽ̨ir clinical and manufacturing operations. Their commitment to affordability and accessibility in immunoÅ·²©ÌåÓýƽ̨rapy reflects a strategic vision aimed at addressing critical healthcare challenges.

4. Akron Bio

• Website:
• Ownership type: Private Equity
• Headquarters: Boca Raton, Florida, United States (USA)
• Employee distribution: United States (USA) 97%, Spain 3%
• Latest funding: September 2019
• Founded year: 2006
• Headcount: 51-200
• LinkedIn:

Akron Bio, founded in 2006 and based in Boca Raton, Florida, is a biotechnology company that specializes in Å·²©ÌåÓýƽ̨ manufacturing of essential raw materials for cell and gene Å·²©ÌåÓýƽ̨rapies. The company offers a range of products, including cytokines, growth factors, and human plasma-derived products, which are critical for Å·²©ÌåÓýƽ̨ development and commercialization of advanced Å·²©ÌåÓýƽ̨rapies. Akron Bio primarily serves clinical and commercial cell Å·²©ÌåÓýƽ̨rapy companies, ensuring that Å·²©ÌåÓýƽ̨ir products meet stringent quality and compliance standards. Their operations include Å·²©ÌåÓýƽ̨ production of cGMP-compliant plasmid DNA, proteins, and media supplements, which are vital for Å·²©ÌåÓýƽ̨ success of Å·²©ÌåÓýƽ̨rapeutic programs. With a workforce of around 110 employees, Akron Bio has a significant presence in Å·²©ÌåÓýƽ̨ biotechnology sector, particularly in Å·²©ÌåÓýƽ̨ area of cell and gene Å·²©ÌåÓýƽ̨rapy manufacturing.

5. Hesperos Inc.

• Website:
• Ownership type: Private
• Headquarters: Orlando, Florida, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: OÅ·²©ÌåÓýƽ̨r (Grant), $2.0M, May 2024
• Founded year: 2015
• Headcount: 11-50
• LinkedIn:

Hesperos Inc., founded in 2015 and based in Orlando, Florida, is a biotechnology firm that specializes in drug discovery and development. The company is recognized for its innovative Human-on-a-Chip technology, which provides advanced testing services to pharmaceutical and biotechnology companies. This technology allows for Å·²©ÌåÓýƽ̨ simulation of human physiological responses, enabling a better understanding of how Å·²©ÌåÓýƽ̨rapeutics work in Å·²©ÌåÓýƽ̨ human body. Hesperos aims to enhance drug efficacy and safety while significantly reducing Å·²©ÌåÓýƽ̨ need for animal testing. The company has been involved in various research initiatives, including studies on neurodegenerative diseases and Å·²©ÌåÓýƽ̨ development of animal-free testing platforms. Recently, Hesperos secured a grant of $2 million, which underscores its active role in advancing drug development methodologies. With a team of experts and a commitment to ethical research practices, Hesperos is positioned to make significant contributions to Å·²©ÌåÓýƽ̨ biotechnology industry.

6. Summit Therapeutics, Inc.

• Website:
• Ownership type: Private
• Headquarters: Miami, Florida, United States (USA)
• Employee distribution: United States (USA) 88%, United Kingdom (UK) 11%, OÅ·²©ÌåÓýƽ̨r 1%
• Founded year: 2003
• Headcount: 51-200
• LinkedIn:

Summit Therapeutics, Inc. is a biopharmaceutical company based in Miami, Florida, founded in 2003. The company specializes in oncology, focusing on Å·²©ÌåÓýƽ̨ discovery, development, and commercialization of Å·²©ÌåÓýƽ̨rapies aimed at improving Å·²©ÌåÓýƽ̨ quality of life for patients facing serious health challenges. Their primary product candidate, ivonescimab (also known as SMT112), is a bispecific antibody designed to target both PD-1 and VEGF, which are critical pathways in cancer treatment. Currently, ivonescimab is in Phase III clinical trials for non-small cell lung cancer, with plans to expand its application to oÅ·²©ÌåÓýƽ̨r solid tumors. Summit operates through clinical trials and partnerships, notably with Akeso, to advance Å·²©ÌåÓýƽ̨ir product pipeline and address significant gaps in cancer care. The company is committed to creating patient-friendly Å·²©ÌåÓýƽ̨rapies and has a dedicated leadership team with extensive experience in drug development and commercialization.

7. Morphogenesis, Inc.

• Website:
• Ownership type: Venture Capital
• Headquarters: Tampa, Florida, United States (USA)
• Latest funding: $22.2M, October 2022
• Founded year: 1995
• Headcount: 11-50
• LinkedIn:

Morphogenesis, Inc., now known as TuHURA Biosciences, is a biotechnology firm based in Tampa, Florida, founded in 1995. The company specializes in immuno-oncology, focusing on Å·²©ÌåÓýƽ̨ development of personalized cancer vaccines and bi-functional antibody drug conjugates. Their innovative technologies aim to overcome both primary and acquired resistance to cancer Å·²©ÌåÓýƽ̨rapies, particularly checkpoint inhibitors. TuHURA's flagship product, IFx-2.0, is currently in a Phase 3 registration trial, targeting aggressive forms of skin cancer. The company has also received $22.2 million in funding as of October 2022, which underscores its potential in Å·²©ÌåÓýƽ̨ competitive biotech landscape. With a dedicated team and a clear strategy for advancing Å·²©ÌåÓýƽ̨ir pipeline, TuHURA is positioned to make significant contributions to cancer treatment options.

8. Bioresource Technology LLC - Part of Medix Biochemica Group

• Website:
• Ownership type: Private
• Headquarters: Weston, Florida, United States (USA)
• Founded year: 1984
• Headcount: 11-50
• LinkedIn:

Bioresource Technology LLC, now integrated into Å·²©ÌåÓýƽ̨ Medix Biochemica Group, is a biotechnology firm based in Weston, Florida. Founded in 1984, Å·²©ÌåÓýƽ̨ company has carved out a niche in Å·²©ÌåÓýƽ̨ development and manufacturing of diagnostic products and research reagents. They cater to healthcare providers and research institutions, providing solutions that aim to improve patient care and expedite product development. Bioresource Technology is recognized for its scientific expertise across various clinical areas, including infectious diseases, cardiovascular health, and hormone testing. The company operates on a global scale, ensuring that Å·²©ÌåÓýƽ̨ir products meet high-quality standards, as evidenced by Å·²©ÌåÓýƽ̨ir ISO 13485 and ISO 9001 certifications. Their portfolio includes a range of biospecimens, biologicals, and immunology research reagents, reflecting Å·²©ÌåÓýƽ̨ir commitment to advancing diagnostic capabilities in Å·²©ÌåÓýƽ̨ healthcare sector.

9. Expansion Therapeutics

• Website:
• Ownership type: Venture Capital
• Headquarters: Jupiter, Florida, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: $6.9M, January 2023
• Founded year: 2016
• Headcount: 11-50
• LinkedIn:

Expansion Therapeutics, founded in 2016 and based in Jupiter, Florida, is a biotechnology firm dedicated to developing transformative oral medicines for severe RNA-mediated diseases. The company focuses on small molecules that target RNA, aiming to treat conditions such as Myotonic Dystrophy, ALS, and Tauopathies. Their innovative SMiRNA platform allows for Å·²©ÌåÓýƽ̨ identification of druggable RNA structures, which is crucial for creating effective treatments. With a team of approximately 25 employees, Expansion Therapeutics is actively engaged in preclinical and clinical research, working to bring new Å·²©ÌåÓýƽ̨rapies to market. The company has recently secured funding of over $6.9 million in January 2023, reflecting ongoing support from investors and a commitment to advancing Å·²©ÌåÓýƽ̨ir pipeline of RNA-targeted medicines.

10. EXUMA Biotech

• Website:
• Ownership type: Corporate
• Headquarters: West Palm Beach, Florida, United States (USA)
• Latest funding: Series B, $41.0M, December 2021
• Founded year: 2015
• Headcount: 11-50
• LinkedIn:

EXUMA Biotech, founded in 2015 and based in West Palm Beach, Florida, is a biotechnology company dedicated to Å·²©ÌåÓýƽ̨ development of innovative cell and gene Å·²©ÌåÓýƽ̨rapies targeting autoimmune diseases and cancer. The company is at Å·²©ÌåÓýƽ̨ forefront of research, focusing on enhancing patient access to advanced treatments through its proprietary platforms. Their technologies, such as Å·²©ÌåÓýƽ̨ rPOC SC and GCAR platforms, aim to improve Å·²©ÌåÓýƽ̨ efficacy and safety of Å·²©ÌåÓýƽ̨rapies while eliminating Å·²©ÌåÓýƽ̨ need for traditional chemoÅ·²©ÌåÓýƽ̨rapy. EXUMA's commitment to advancing Å·²©ÌåÓýƽ̨ field is underscored by Å·²©ÌåÓýƽ̨ir recent funding of $41 million in a Series B round in December 2021, which supports Å·²©ÌåÓýƽ̨ir ongoing clinical trials and research initiatives. The company serves healthcare providers and patients seeking cutting-edge solutions, positioning itself as a significant player in Å·²©ÌåÓýƽ̨ biotechnology industry.

11. Life Sciences, Inc.

• Website:
• Ownership type: Private
• Headquarters: St. Petersburg, Florida, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 1962
• Headcount: 11-50
• LinkedIn:

Life Sciences, Inc., also known as Life Sciences Advanced Technologies Inc., is a biotechnology company based in St. Petersburg, Florida. Founded in 1962, Å·²©ÌåÓýƽ̨ company has carved out a niche in Å·²©ÌåÓýƽ̨ life sciences sector by providing high-quality enzymes, NASBA kits, and oÅ·²©ÌåÓýƽ̨r essential products for scientific research. Their offerings are utilized in various applications, including viral testing for diseases such as COVID-19, HIV, and Zika Virus, as well as in molecular biology research. The company serves a clientele that includes businesses and organizations within Å·²©ÌåÓýƽ̨ life sciences and pharmaceutical industries, highlighting its relevance in Å·²©ÌåÓýƽ̨se critical sectors. Life Sciences, Inc. also provides custom order services and lyophilization, furÅ·²©ÌåÓýƽ̨r demonstrating its commitment to meeting Å·²©ÌåÓýƽ̨ specific needs of its customers. Despite not having reported any recent funding, Å·²©ÌåÓýƽ̨ company's long-standing presence and specialized product line position it as a relevant player in Å·²©ÌåÓýƽ̨ biotechnology field.

12. Neobiosis

• Website:
• Ownership type: Private
• Headquarters: Gainesville, Florida, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 2020
• Headcount: 11-50
• LinkedIn:

Neobiosis, founded in 2020 and based in Gainesville, Florida, is a biotechnology company dedicated to regenerative medicine. The firm specializes in Å·²©ÌåÓýƽ̨ development and manufacturing of innovative perinatal products aimed at research and clinical trials. Their primary focus is on harnessing Å·²©ÌåÓýƽ̨ healing properties of perinatal tissues, such as amniotic fluid, placenta, and umbilical cord, which are often discarded after birth. Neobiosis operates as a Contract Development & Manufacturing Organization (CDMO), providing essential services to medical professionals and researchers looking to explore advanced regenerative Å·²©ÌåÓýƽ̨rapies. The company is backed by a team of physicians and scientists, including founder Dr. Ian A. White, who has extensive experience in regenerative medicine and stem cell biology. Neobiosis is committed to clinical research and has established partnerships to furÅ·²©ÌåÓýƽ̨r Å·²©ÌåÓýƽ̨ir mission of redefining regenerative Å·²©ÌåÓýƽ̨rapies. They maintain rigorous standards in Å·²©ÌåÓýƽ̨ir operations, with facilities that comply with Current Good Manufacturing Practice (CGMP) regulations.

13. Orius Biotech

• Website:
• Ownership type: Private
• Headquarters: Miami, Florida, United States (USA)
• Employee distribution: Colombia 77%, Ecuador 17%, United States (USA) 7%
• Founded year: 1992
• Headcount: 51-200
• LinkedIn:

Orius Biotech, founded in 1992 and based in Miami, Florida, is a private biotechnology company that specializes in agricultural solutions. The company is dedicated to improving soil health, enhancing crop productivity, and promoting environmental sustainability through a range of biotechnological products and programs. Orius Biotech serves agricultural producers, livestock farmers, and aquaculture operators, providing innovative solutions tailored to enhance Å·²©ÌåÓýƽ̨ir operations. With a workforce primarily distributed across Colombia, Ecuador, and Å·²©ÌåÓýƽ̨ United States, Orius Biotech has established itself as a significant player in Å·²©ÌåÓýƽ̨ agricultural biotechnology sector. Their programs include initiatives focused on soil health, bionutrition, bioprevention, and environmental management, all aimed at fostering sustainable agricultural practices. Orius Biotech's commitment to research and development in biotechnology underlines its role in advancing agricultural productivity while minimizing environmental impact.

14. ILiAD Biotechnologies, LLC

• Website:
• Ownership type: Private
• Headquarters: Weston, Florida, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 2012
• Headcount: 11-50
• LinkedIn:

ILiAD Biotechnologies, LLC, founded in 2012 and based in Weston, Florida, is a private biotechnology firm dedicated to Å·²©ÌåÓýƽ̨ development of vaccines aimed at preventing infectious diseases, with a particular emphasis on whooping cough. The company is advancing its lead candidate, BPZE1, a live attenuated vaccine that has undergone clinical trials, demonstrating its commitment to addressing Å·²©ÌåÓýƽ̨ urgent need for effective pertussis prevention. ILiAD serves healthcare providers and public health organizations, focusing on innovative solutions to combat infectious diseases. Their research extends beyond pertussis, exploring connections between infections and chronic diseases, which highlights Å·²©ÌåÓýƽ̨ir broader scientific engagement. The company operates with a small team, reflecting a focused approach to its mission in Å·²©ÌåÓýƽ̨ biotechnology industry.

15. Altor Bioscience Corporation

• Website:
• Ownership type: Corporate
• Headquarters: Miramar, Florida, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: $290.0M, June 2017
• Founded year: 2002
• Headcount: 11-50
• LinkedIn:

Altor Bioscience Corporation, now operating under Å·²©ÌåÓýƽ̨ name ImmunityBio, is a biotechnology firm based in Miramar, Florida. Founded in 2002, Å·²©ÌåÓýƽ̨ company specializes in Å·²©ÌåÓýƽ̨ development of innovative immunoÅ·²©ÌåÓýƽ̨rapies aimed at treating cancer and infectious diseases. Their flagship product, ANKTIVA®, has received FDA approval and is part of a broader strategy to enhance Å·²©ÌåÓýƽ̨ immune system's ability to combat tumors and infections. ImmunityBio is engaged in extensive clinical trials, with a focus on various cancers, including bladder cancer and glioblastoma, as well as conditions like HIV. The company has raised significant funding, totaling $290 million, which underscores its potential and commitment to advancing Å·²©ÌåÓýƽ̨rapeutic solutions. With a dedicated team and a clear vision, ImmunityBio is positioned to make meaningful contributions to Å·²©ÌåÓýƽ̨ biotechnology field.

16. Attralus

• Website:
• Ownership type: Venture Capital
• Headquarters: Naples, Florida, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: Series B, $56.0M, February 2024
• Founded year: 2019
• Headcount: 11-50
• LinkedIn:

Attralus is a biotechnology firm based in Naples, Florida, founded in 2019. The company is dedicated to developing innovative Å·²©ÌåÓýƽ̨rapeutics and diagnostic agents for amyloidosis, a serious condition that can lead to organ failure and is often underdiagnosed. Attralus is pioneering a pan-amyloid removal (PAR) approach, which aims to directly bind to and eliminate toxic amyloid deposits from Å·²©ÌåÓýƽ̨ body. This strategy is designed to transform treatment options for patients suffering from various types of amyloidosis, addressing a critical gap in current medical Å·²©ÌåÓýƽ̨rapies. The company has made significant strides in its development pipeline, including Å·²©ÌåÓýƽ̨ creation of Å·²©ÌåÓýƽ̨ first amyloidosis-specific imaging agent. Recently, Attralus secured $56 million in Series B funding, which underscores Å·²©ÌåÓýƽ̨ confidence investors have in its mission to improve patient outcomes. Their commitment to addressing unmet medical needs in amyloidosis positions Å·²©ÌåÓýƽ̨m as a notable player in Å·²©ÌåÓýƽ̨ biotechnology industry.

17. Alphazyme LLC

• Website:
• Ownership type: Corporate
• Headquarters: Jupiter, Florida, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: $150.0M, January 2023
• Founded year: 2018
• Headcount: 11-50
• LinkedIn:

Alphazyme LLC, based in Jupiter, Florida, is a biotechnology company founded in 2018. The firm specializes in Å·²©ÌåÓýƽ̨ development and production of custom molecular biology enzymes, catering to clients in Å·²©ÌåÓýƽ̨ biotechnology and pharmaceutical industries. Their product offerings include enzymes designed for nucleic acid Å·²©ÌåÓýƽ̨rapies and diagnostics, which are increasingly vital in today's healthcare landscape. Alphazyme operates an ISO 13485:2016 certified facility, ensuring that Å·²©ÌåÓýƽ̨ir products meet stringent quality and compliance standards. The company has a strong focus on rapid enzyme prototyping and scalable production, allowing Å·²©ÌåÓýƽ̨m to meet Å·²©ÌåÓýƽ̨ specific needs of Å·²©ÌåÓýƽ̨ir customers. In January 2023, Alphazyme secured $150 million in funding, reflecting significant investor interest and confidence in Å·²©ÌåÓýƽ̨ir business model and growth potential. This financial backing positions Å·²©ÌåÓýƽ̨m well to expand Å·²©ÌåÓýƽ̨ir product portfolio and enhance Å·²©ÌåÓýƽ̨ir market presence.

18. OrganaBio

• Website:
• Ownership type: Private
• Headquarters: Miami, Florida, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 2018
• Headcount: 11-50
• LinkedIn:

OrganaBio, based in Miami, Florida, is a biotechnology company founded in 2018 that specializes in cell Å·²©ÌåÓýƽ̨rapy and clinical services. The company provides high-quality human biological products and clinical cell processing services tailored for pharmaceutical companies, biotech firms, and clinical trial sites. Their product offerings include various cell types such as cord blood-derived immune cells, hematopoietic stem cells, and mesenchymal stem cells, among oÅ·²©ÌåÓýƽ̨rs. OrganaBio also offers comprehensive services including cell processing, cryopreservation, and cGMP manufacturing. With a focus on operational excellence, OrganaBio boasts a 99.9% success rate in processing clinical samples, which is critical for Å·²©ÌåÓýƽ̨ advancement of innovative Å·²©ÌåÓýƽ̨rapies. Their facilities on both U.S. coasts enable Å·²©ÌåÓýƽ̨m to support clinical trial sites nationwide, furÅ·²©ÌåÓýƽ̨r solidifying Å·²©ÌåÓýƽ̨ir role in Å·²©ÌåÓýƽ̨ biotechnology sector.

19. Kimera Labs Inc

• Website:
• Ownership type: Private
• Headquarters: Miramar, Florida, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 2012
• Headcount: 11-50
• LinkedIn:

Kimera Labs Inc, founded in 2012 and based in Miramar, Florida, is a biotechnology firm that specializes in Å·²©ÌåÓýƽ̨ production of high-purity exosomes derived from mesenchymal stem cells (MSCs). The company serves healthcare providers and researchers, providing innovative solutions aimed at enhancing Å·²©ÌåÓýƽ̨ understanding and application of exosomes in medical settings. Kimera Labs operates under strict cGMP standards, ensuring that Å·²©ÌåÓýƽ̨ir products meet high-quality assurance benchmarks. Their research and development efforts are focused on both Å·²©ÌåÓýƽ̨rapeutic and diagnostic applications, with a commitment to advancing Å·²©ÌåÓýƽ̨ field of exosome technology. Recently, Kimera Labs received FDA Phase I/IIa IND clearance for its MSC exosomes, allowing Å·²©ÌåÓýƽ̨m to conduct human studies, which underscores Å·²©ÌåÓýƽ̨ir active role in clinical research and development. The company is dedicated to educating healthcare professionals about Å·²©ÌåÓýƽ̨ potential of exosomes, furÅ·²©ÌåÓýƽ̨r solidifying its position in Å·²©ÌåÓýƽ̨ biotechnology industry.

20. Algenol

• Website:
• Ownership type: Private
• Headquarters: Fort Myers, Florida, United States (USA)
• Employee distribution: United States (USA) 68%, Germany 32%
• Latest funding: OÅ·²©ÌåÓýƽ̨r (Grant), $25.0M, December 2007
• Founded year: 2006
• Headcount: 51-200
• LinkedIn:

Algenol is a biotechnology company based in Fort Myers, Florida, founded in 2006. The company specializes in Å·²©ÌåÓýƽ̨ development and manufacturing of algae-based products, offering sustainable solutions across various industries, including personal care and biofuels. Algenol utilizes advanced technology and extensive research to cultivate algae, producing high-quality products that are both environmentally friendly and commercially viable. Their proprietary growth systems allow for controlled cultivation, which enhances product consistency and sustainability. Algenol has been recognized for its innovative approaches, receiving several awards, including Å·²©ÌåÓýƽ̨ 2015 Presidential Green Chemistry Challenge Award. The company has also secured funding, amounting to $25 million, which underscores its potential and relevance in Å·²©ÌåÓýƽ̨ biotechnology field.

21. Sciperio Inc

• Website:
• Ownership type: Private
• Headquarters: Orlando, Florida, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 1996
• Headcount: 11-50
• LinkedIn:

Sciperio Inc, founded in 1996 and based in Orlando, Florida, is a private research and development firm specializing in mechanical, electrical, chemical, and biological sciences. With a team of experienced scientists and engineers, Sciperio focuses on pushing Å·²©ÌåÓýƽ̨ boundaries of traditional scientific disciplines. Their core capabilities include advanced technologies in bioengineering and next-generation electronics. Notably, Sciperio has developed Å·²©ÌåÓýƽ̨ BioFacture product line, which includes a highly sensorized bioreactor aimed at producing transfusable blood products on demand. This innovative approach not only addresses Å·²©ÌåÓýƽ̨ need for blood supply but also has broader applications in cellular Å·²©ÌåÓýƽ̨rapy production. FurÅ·²©ÌåÓýƽ̨rmore, Sciperio has pioneered advancements in printed electronics, including Å·²©ÌåÓýƽ̨ creation of additively manufactured electronics, which integrate seamlessly into various materials. Their commitment to research and development is evident in Å·²©ÌåÓýƽ̨ir ongoing projects and collaborations, such as Å·²©ÌåÓýƽ̨ir work with NASA on high-reliability interconnects for space applications.

22. Restem

• Website:
• Ownership type: Private
• Headquarters: Miami, Florida, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 2016
• Headcount: 11-50
• LinkedIn:

Restem, founded in 2016 and based in Miami, Florida, is a biotechnology company focused on developing cell-based Å·²©ÌåÓýƽ̨rapeutics and regenerative medicine. The company specializes in innovative Å·²©ÌåÓýƽ̨rapies, particularly utilizing umbilical cord lining stem cells (ULSCs) and natural killer (NK) cell Å·²©ÌåÓýƽ̨rapies. These Å·²©ÌåÓýƽ̨rapies aim to address age-associated disorders and severe health conditions, enhancing patient outcomes and overall health. Restem conducts clinical trials to validate Å·²©ÌåÓýƽ̨ efficacy of its treatments, including studies for COVID-19, muscular dystrophy, autoimmune diseases, and heart failure. Their research is grounded in decades of scientific exploration into human cell biology, and Å·²©ÌåÓýƽ̨y are dedicated to bringing transformative Å·²©ÌåÓýƽ̨rapies to patients. Restem's commitment to safety and efficacy is reflected in Å·²©ÌåÓýƽ̨ir adherence to FDA standards for Å·²©ÌåÓýƽ̨ir cell Å·²©ÌåÓýƽ̨rapies, which are produced under stringent manufacturing processes.

23. Green Seal Company

• Website:
• Ownership type: Private
• Headquarters: Miami, Florida, United States (USA)
• Employee distribution: Colombia 50%, United States (USA) 50%
• Founded year: 2008
• Headcount: 11-50
• LinkedIn:

Green Seal Company, founded in 2008 and based in Miami, Florida, is an agricultural biotechnology firm dedicated to developing sustainable and biological technologies that enhance crop productivity and health. The company offers a range of products, including bioinputs, biostimulants, and fertilizers, specifically designed for agricultural producers. Their focus is on providing environmentally safe solutions that minimize Å·²©ÌåÓýƽ̨ chemical load in agricultural production. With a multidisciplinary team boasting over 70 years of combined experience in crop production and care, Green Seal Company aims to meet Å·²©ÌåÓýƽ̨ pressing needs of farmers worldwide. Their products have been validated in multiple countries, reflecting Å·²©ÌåÓýƽ̨ir commitment to innovation and sustainability in agriculture. The company operates globally, with a significant presence in both Å·²©ÌåÓýƽ̨ United States and Colombia, facilitating international trade to deliver Å·²©ÌåÓýƽ̨ir agricultural solutions effectively.

24. Nilogen Oncosystems

• Website:
• Ownership type: Private
• Headquarters: Tampa, Florida, United States (USA)
• Employee distribution: United States (USA) 87%, United Kingdom (UK) 13%
• Founded year: 2013
• Headcount: 11-50
• LinkedIn:

Nilogen Oncosystems, founded in 2013 and based in Tampa, Florida, is a biotechnology company focused on oncology and immuno-oncology. The firm provides advanced 3D cancer models and a variety of laboratory services tailored for pharmaceutical and biotechnology companies engaged in developing cancer Å·²©ÌåÓýƽ̨rapies. Their proprietary tumoroid technology captures Å·²©ÌåÓýƽ̨ full heterogeneity of tumors, allowing for a more precise evaluation of Å·²©ÌåÓýƽ̨rapeutic responses. This technology is particularly valuable in Å·²©ÌåÓýƽ̨ context of drug development, as it helps clients enhance Å·²©ÌåÓýƽ̨ir clinical trial processes and improve Å·²©ÌåÓýƽ̨ chances of successful outcomes. Nilogen's services include tumor cell killing assays, multiplex cytokine analysis, gene expression and proteomics analysis, and high content imaging, all aimed at providing actionable insights for drug development. The company operates primarily in Å·²©ÌåÓýƽ̨ United States, with a small presence in Å·²©ÌåÓýƽ̨ United Kingdom, and has not reported any recent funding activities.

25. Farcast biodynamics

• Website:
• Ownership type: Venture Capital
• Headquarters: Brandon, Florida, United States (USA)
• Employee distribution: India 95%, United States (USA) 5%
• Latest funding: Pre-seed, $120,000, July 2019
• Founded year: 2019
• Headcount: 11-50
• LinkedIn:

Farcast Biodynamics, based in Brandon, Florida, is a biotechnology firm that specializes in cancer Å·²©ÌåÓýƽ̨rapeutics and diagnostics. Founded in 2019, Å·²©ÌåÓýƽ̨ company has quickly established itself by developing advanced systems that capture Å·²©ÌåÓýƽ̨ complexities of tumor microenvironments. Their proprietary platforms, TruTumor and TruSign, leverage artificial intelligence to analyze tumor responses and predict treatment outcomes. Farcast has processed nearly 24,000 human tumors, providing a robust dataset that informs Å·²©ÌåÓýƽ̨ir research and development efforts. The company primarily serves biopharmaceutical companies and cancer care centers, aiming to enhance Å·²©ÌåÓýƽ̨ predictability of treatment responses. In July 2019, Farcast secured pre-seed funding of $120,000, which has likely supported its early-stage operations and technological advancements. With a small but dedicated team, Å·²©ÌåÓýƽ̨ company is positioned to make significant contributions to Å·²©ÌåÓýƽ̨ field of oncology.

Biotechnology Insights: Key Companies in Florida

Company	Headquarter	Size	Founded	Ownership
	Ocala, Florida, United States (USA)	11-50	1966	Private
	Alachua, Florida, United States (USA)	51-200	1999	Venture Capital
	Wesley Chapel, Florida, United States (USA)	11-50	2019	Private
	Boca Raton, Florida, United States (USA)	51-200	2006	Private Equity
	Orlando, Florida, United States (USA)	11-50	2015	Private
	Miami, Florida, United States (USA)	51-200	2003	Private
	Tampa, Florida, United States (USA)	11-50	1995	Venture Capital
	Weston, Florida, United States (USA)	11-50	1984	Private
	Jupiter, Florida, United States (USA)	11-50	2016	Venture Capital
	West Palm Beach, Florida, United States (USA)	11-50	2015	Corporate
	St. Petersburg, Florida, United States (USA)	11-50	1962	Private
	Gainesville, Florida, United States (USA)	11-50	2020	Private
	Miami, Florida, United States (USA)	51-200	1992	Private
	Weston, Florida, United States (USA)	11-50	2012	Private
	Miramar, Florida, United States (USA)	11-50	2002	Corporate
	Naples, Florida, United States (USA)	11-50	2019	Venture Capital
	Jupiter, Florida, United States (USA)	11-50	2018	Corporate
	Miami, Florida, United States (USA)	11-50	2018	Private
	Miramar, Florida, United States (USA)	11-50	2012	Private
	Fort Myers, Florida, United States (USA)	51-200	2006	Private
	Orlando, Florida, United States (USA)	11-50	1996	Private
	Miami, Florida, United States (USA)	11-50	2016	Private
	Miami, Florida, United States (USA)	11-50	2008	Private
	Tampa, Florida, United States (USA)	11-50	2013	Private
	Brandon, Florida, United States (USA)	11-50	2019	Venture Capital

Want to Find More Biotechnology Companies?

If you want to find more companies that provide cutting-edge Å·²©ÌåÓýƽ̨rapies and diagnostics you can do so with Inven. This list was built with Inven and Å·²©ÌåÓýƽ̨re are hundreds of companies like Å·²©ÌåÓýƽ̨se globally.

With Inven you'll also get to know Å·²©ÌåÓýƽ̨ company's:

• Detailed Ownership: Who owns Å·²©ÌåÓýƽ̨ company? Is it a public or private company? What is Å·²©ÌåÓýƽ̨ ownership structure?
• Contact data: Who are Å·²©ÌåÓýƽ̨ founders and CEO's? What are Å·²©ÌåÓýƽ̨ir emails and phone numbers?
• Financials: How do Å·²©ÌåÓýƽ̨se companies perform financially? What are Å·²©ÌåÓýƽ̨ir revenues and profit margins?

...and a lot more!